Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery Cytokeratin 6
Path
Created with Sketch.
Go to Cytokeratin 6 Normal Tissue Gallery
Go back to Product Page
Adenocarcinoma of the pancreas with moderate KRT6 immunostaining.
Adenocarcinoma of the pancreas with moderate KRT6 immunostaining.
Basal cell carcinoma of the skin with only few scattered cytokeratin 6 positive cells.
Basal cell carcinoma of the skin with only few scattered cytokeratin 6 positive cells.
Breast cancer of no special type (NST) showing strong diffuse KRT6 positivity.
Breast cancer of no special type (NST) showing strong diffuse KRT6 positivity.
Breast cancer of no special type (NST) showing strong KRT6 expression in a small fraction of tumor cells.
Breast cancer of no special type (NST) showing strong KRT6 expression in a small fraction of tumor cells.
Cholangiocellular carcinoma of the liver with strong KRT6 immunostaining in 90% of cells.
Cholangiocellular carcinoma of the liver with strong KRT6 immunostaining in 90% of cells.
Colorectal adenocarcinoma with KRT6 immunostaining in about 20% of tumor cells.
Colorectal adenocarcinoma with KRT6 immunostaining in about 20% of tumor cells.
Colorectal adenocarcinoma with strong KRT6 positivity in about 50% of tumor cells.
Colorectal adenocarcinoma with strong KRT6 positivity in about 50% of tumor cells.
Cytokeratin 6 staining is only focally seen in a basal cell carcinoma while the overlying skin stains positive.
Cytokeratin 6 staining is only focally seen in a basal cell carcinoma while the overlying skin stains positive.
Focal KRT6 immunostaining in an adenocarcinoma of the pancreas.
Focal KRT6 immunostaining in an adenocarcinoma of the pancreas.
Gastric adenocarcinoma with strong KRT6 expression.
Gastric adenocarcinoma with strong KRT6 expression.
KRT6 negative breast cancer.
KRT6 negative breast cancer.
KRT6 positivity in a breast cancer of no special type (NST).
KRT6 positivity in a breast cancer of no special type (NST).
Laryngeal squamous cell carcinoma with intense Cytokeratin 6 immunostaining.
Laryngeal squamous cell carcinoma with intense Cytokeratin 6 immunostaining.
Squamous cell carcinoma of larynx with strong cytokeratin 6 immunostaining.
Squamous cell carcinoma of larynx with strong cytokeratin 6 immunostaining.
Squamous cell carcinoma of the oral cavity with strong cytokeratin 6 immunostaining.
Squamous cell carcinoma of the oral cavity with strong cytokeratin 6 immunostaining.
Squamous cell carcinoma of the uterine cervix with strong Cytokeratin 6 positivity.
Squamous cell carcinoma of the uterine cervix with strong Cytokeratin 6 positivity.
Strong Cytokeratin 6 immunostaining in a squamous cell carcinoma of the penis.
Strong Cytokeratin 6 immunostaining in a squamous cell carcinoma of the penis.
Strong Cytokeratin 6 immunostaining in a squamous cell carcinoma of the vulva.
Strong Cytokeratin 6 immunostaining in a squamous cell carcinoma of the vulva.
Strong KRT6 immunostaining in a colorectal adenocarcinoma.
Strong KRT6 immunostaining in a colorectal adenocarcinoma.
Strong KRT6 immunostaining in an adenocarcinoma of the stomach (diffuse type).
Strong KRT6 immunostaining in an adenocarcinoma of the stomach (diffuse type).